[(2R)-1-[(3R)-4-(cyclopropanecarbonyl)-3-methylpiperazin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium
C18H26N3O2+ — CID 6941213
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2R)-1-[(3R)-4-(cyclopropanecarbonyl)-3-methylpiperazin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium
[(2R)-1-[(3R)-4-(cyclopropanecarbonyl)-3-methylpiperazin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium (PubChem CID 6941213) has the molecular formula C18H26N3O2+ and a molecular weight of 316.42 g/mol. Its IUPAC name is [(2R)-1-[(3R)-4-(cyclopropanecarbonyl)-3-methylpiperazin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium.
Molecular Properties
| Compound Name | [(2R)-1-[(3R)-4-(cyclopropanecarbonyl)-3-methylpiperazin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium |
|---|---|
| PubChem CID | 6941213 |
| Molecular Formula | C18H26N3O2+ |
| Molecular Weight | 316.42 g/mol |
| Exact Mass | 316.20 |
| IUPAC Name | [(2R)-1-[(3R)-4-(cyclopropanecarbonyl)-3-methylpiperazin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium |
| SMILES | C[C@@H]1CN(C(=O)[C@H]([NH3+])Cc2ccccc2)CCN1C(=O)C1CC1 |
| InChI | InChI=1S/C18H25N3O2/c1-13-12-20(9-10-21(13)17(22)15-7-8-15)18(23)16(19)11-14-5-3-2-4-6-14/h2-6,13,15-16H,7-12,19H2,1H3/p+1/t13-,16-/m1/s1 |
| InChIKey | CNQGDLLSWFDWFH-CZUORRHYSA-O |
| XLogP | 0.31 |
| TPSA | 68.26 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 316.42 |
| LogP ≤ 5 | 0.31 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 6941213 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.